Search results for "slas europe 2018"

Dr. Timothy Maul discusses the challenges of patient blood management during ECMO and the impact of accurate POC devices for clinical decision making

In this guest editorial, Dr. Anurag Singh discusses gastroenteritis diagnosis and how syndromic testing is establishing its role in the future of infectious disease management

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research

CE marking under IVDR is part of a comprehensive plan and resources to help customers navigate the IVDR marathon

Understand and manage the performance of your automated liquid handlers, multichannel pipettes, labware, operators, and more.

1 vial (2.8E+08 – 4.7E+08 capsids)

Cyto-Mine Chroma is a multiplexing-capable, fully-automated single cell analysis platform that can encapsulate, analyze, sort, and dispense viable single cells

STEM-CELLBANKER® is a chemically defined, animal-free freezing medium manufactured under GMP conditions- optimized for ES cell and iPS cell storage as well as other valuable cell types.

Nanoparticle Size and Zeta Potential Analyzer

Marian Burducea discusses the main challenges encountered by a young researcher and the crucial need for science collaboration in a post-pandemic world

The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organization

Advancing global operations and realigning domestic sites to strengthen the organization

Shimadzu call for applications to their ‘lab4you’ program for young scientists

As sponsor–CRO collaborations become even more central to drug discovery, fragmented data and manual processes continue to slow progress – but more structured, connected workflows are beginning to reshape how teams share and act on information

Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions

Enhancing breast cancer diagnostics with precision, efficiency, and improved grading consistency for better patient outcomes

Quality control of cell lines to improve validity in cell culture research.

The INTERCEPT Blood System, pathogen reduction system, a proactive approach to TTI risk reduction provides continued protection against TTIs through broad spectrum inactivation of viruses, bacteria, and parasites. INTERCEPT is approved as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD) in platelet components.

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic